Search

Search Constraints

You searched for: Author/Creator Marrone, A.

Search Results

1. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015)

2. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. Issue 8 (7th January 2013)

3. Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy. Issue 2 (29th November 2017)

4. Entecavir monotherapy improves renal function in patients developing renal side effects during long-term tenofovir treatment without compromising virological response: A multicenter real-life study in 103 patients. Issue 1 (16th February 2017)

7. HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Issue 6 (22nd July 2016)

8. Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis. Issue 1 (February 2018)

9. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016)

10. The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. (June 2015)